Prognostic value of positron emission tomography with [18F]fluoro-2- deoxy-D-glucose in the low-grade glioma

Neurosurgery

Volumn 39, Issue 3, 1996, Pages 470-477

  De Witte, Olivier ^a   Levivier, Marc ^a   Violon, Philippe ^a   Salmon, Isabelle ^a   Damhaut, Philippe ^a   Wikler Jr , David ^a   Hildebrand, Jerzy ^a   Brotchi, Jacques ^a   Goldman, Serge ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Brain neoplasm; Fluorodeoxyglucose; Glucose metabolism; Low grade glioma; Positron emission tomography

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029770438     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199609000-00007     Document Type: Article

References (42)

1. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. Cancer 62:1074-1078, 1988.
2. 18F]fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47-52, 1995.
3. 18F]fluorodeoxyglucose PET study in brain hematoma. J Nucl Med 35:1162-1166, 1994.
4. De Witte O, Hildebrand J, Luxen A, Goldman S: Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 74:2836-2842, 1994.
5. 18F]fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22:360-371, 1986.
6. Di Chiro G, Brooks RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, Mansi L, Barker J: Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15[Suppl]:S138-S146, 1984.
7. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 32:1323-1332, 1982.
8. Di Chiro G, Hatazawa J, Katz DA, Rizzoli HV, De Michele DJ: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study. Radiology 164:521-526, 1987.
9. Francavilla TL, Miletich RS, Di Chiro G, Patronas NJ, Rizzoli HV, Wright DC: Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 24: 1-5, 1989.
10. Fults D, Pedone C: Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom Cancer 7:173-177, 1993.
11. Galarraga J, Loreck DJ, Graham JF, DeLaPaz RL, Smith BH, Hallgren D, Cummins CJ: Glucose metabolism in human gliomas: Correpondence of in situ and in vitro metabolic rates and altered energy metabolism. Metab Brain Dis 1:279-291, 1986.
12. Goldman S, Dethy S, Lotstra F, Biver F, Stanus E, Wilker D, Hildebrand J, Mendlewicz J, Luxen A: Basal ganglia and frontal lobe glucose metabolism. J Neuroimaging 5:219-226, 1995.
13. Graham JF, Cummins CJ, Smith BH, Kornblith PL: Regulation of hexokinase in cultured gliomas. Neurosurgery 17:537-542, 1985.
14. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238, 1986.
15. Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss WD: Correlation of glucose consumption and tumor cell density in astrocytomas. J Neurosurg 79:853-858, 1993.
16. Herholz K, Rudolf J, Heiss WD: FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neurooncol 12:159-165, 1992.
17. Herholz K, Wienhard K, Heiss WD: Validity of PET studies in brain tumors. Cerebrovasc Brain Metab Rev 2:240-265, 1990.
18. 18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33:540-548, 1993.
19. Kelly PJ, Daumas-Duport C, Kispert DB, Kail BA: Imaging-based stereotaxis serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987.
20. 18F]fluorodeoxyglucose. J Neurooncol 10:85-91, 1991.
21. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993.
22. Laws ER Jr, Taylor WF, Bergstralh EJ, Okazaki H, Clifton MB: The neurosurgical management of low grade astrocytoma. Clin Neurosurg 33:575-588, 1986.
23. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H: Neurosurgical management of low grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673, 1984.
24. Leenstra S, Troost D, Hulsebos TJM, Andries Bosch D: Genetic versus histological grading in stereotactic biopsies. Stereotact Funct Neurosurg 63:56-62, 1994.
25. Leenstra S, Troost D, Westerveld A, Andries Bosch D, Hulsebos TJM: Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res 52: 1568-1572, 1992.
26. Levivier M, Goldman S, Bidaut L, Luxen A, Stanus E, Przedborski S, Baleriaux D, Hildebrand J, Brotchi J: Positron emission tomographyguided stereotaxic brain biopsy. Neurosurgery 31:792-797, 1992.
27. 18F]fluorodeoxyglucose. J Neurosurg 82:445-452, 1995.
28. Loiseau H, Bousquet P, Rivel J, Vital C, Kantor G, Rougier A, Dartigues JF, Cohadon F: Astrocytomes de bas grade sustentoriels de l'adulte: Facteurs pronostics et indications thérapeuriques - À propos d'une série de 141 patients. Neurochirurgie 41:38-51, 1995.
29. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J: Treatment and survival of low-grade astrocytoma in adults: 1977-1988. Neurosurgery 31:636-642, 1992.
30. Mineura K, Sasajima T, Kowada H, Ogawa T, Hatazawa J, Shishido F, Uemura K: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73:2386-2394, 1994.
31. Ogawa T, Uemura K, Shishido F, Yamaguchi T, Murakami M, Inugami A, Kanno I, Sasaki H, Hirata K: Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: PET study. J Comput Assist Tomogr 12:290-297, 1988.
32. O'Neil A, Macapinlac H, DeAngelis L: Positron emission tomography hypermetabolism with cerebral radionecrosis, in Proceedings of the Eleventh International Conference on Brain Tumor Research and Therapy. 1995, p 23 (abstr).
33. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816-822, 1985.
34. Perhouse MA, Stubbfield E, Hadi A: Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53:5043-5050, 1993.
35. Pruchon E, Chauveinc L, Sabatier L, Dutrillaux AM, Ricoul M, Delattre JY, Vega F, Poisson M, Hor F, Dutrillaux B: A cytogenetic study of 19 recurrent gliomas. Cancer Genet Cytogenet 76:85-92, 1994.
36. Rozental JM, Levine RL, Mehta MP, Kinsella TJ, Levin AB, Algan O, Mendoza M, Hanson JM, Schrader DA, Nickles RJ: Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy. Int Radiat Oncol Biol Phys 20:1053-1060, 1991.
37. Thiel G, Lozanova T, Vogel S, Kintzel D, Jänisch W, Witkowski R: Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58: 109-120, 1992.
38. Thiel G, Lozanova T, Vogel S, Kintzel D, Jänisch W, Witkowski R: Age-related nonrandom chromosomal abnormalities in human low-grade astrocytomas. Hum Genet 91:547-550, 1993.
39. Vecht CJ: Effect of age on treatment decisions in low-grade glioma. J Neurol Neurosurg Psychiatry 56:1259-1264, 1993.
40. Warburg O: The Metabolism of Tumors. London, Arnold Constable, 1930, pp 75-327.
41. Warburg O: On the origin of cancer cells. Science 123:309-314, 1956.
42. Yamamoto T, Seino Y, Fukomoto H, Koh G, Yano H, Inagak N, Yamada Y, Inoue K, Manabe T, Imura H: Over-expression of facilitate glucose transporter genes in human cancer. Biochem Biophys Res Comm 170:223-230, 1990.